Dr. Prakasha Kempaiah

AbbVie-Loyola University Chicago, USA

Pharmacovigilance Fellow

Email: [email protected]

Qualification

2006 Ph.D., Institute of Human Genetics, Univ. of Goettingen, Germany

2000 M.Sc., Department of Biotechnology, Univ. of Agril Sciences,  India

1997 B.Sc., University of Agril Sciences, Bangalore, India

Publications (Selected)

1. Baghdadi, M.A., do Carmo Las, P.H.F., Mbemba, E., Rousseau, A., Kempaiah, P., et al. LMWHs and DOACs modulate cancer cell procoagulant activity and viability: comparison with quercetin. Preprints, 2026.

2. Abourahma, H., Kempaiah, P., Farooqui, A., Krupa, E., Iqbal, O., Fareed, J., et al. A comparative study of porcine and ovine derived defibrotide: coagulation profiles, molecular characteristics, and DNA content. Clinical and Applied Thrombosis/Hemostasis, 32:10760296261429228, 2026.
3. Zhang, C., Kantarcioglu, B., Kempaiah, P., Nikolovski, S., Siddiqui, F., Kouta, A., et al. Circulating exosomal microRNAs as potential biomarkers for pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis, 32:10760296251407689, 2026.
4. Senthilkumar, S., Chitale, R.A., Kempaiah, P., Saraf, D. and Durvasula, R. Eliminating cervical cancer in India: challenges and prospects. The American Journal of Tropical Medicine and Hygiene, 114(1):6, 2025.
5. Baskaran, N., Baghdadi, M., Las Casas, P.H., Van Dreden, P., Mbemba, E., et al. Fibrin clot shields drive clonal selection of cancer cells: procoagulant properties and proliferative survival of clot embedded cancer cells. Blood, 146:1316, 2025.
6. Las Casas, P.H., Marco Ayala, J., Soares, T.S., Baghdadi, M., Van Dreden, P., et al. Venous thromboembolism in multiple myeloma patients treated with BCMA-directed CAR T-cell therapy: a systematic review and meta-analysis. Blood, 146(Supplement 1):2687-2687, 2025.
7. Kannan, M., Roy, C.L., Kempaiah, P., Ranjan, R., Mahapatra, M., Saxena, R., et al. Comparative efficacy of recombinant FVIII and recombinant FVII biosimilars in severe hemophilia A. Clinical and Applied Thrombosis/Hemostasis, 31:10760296251329329, 2025.
8. Dieter, R.S., Kempaiah, P., Dieter, E.G., Alcazar, A., Tafur, A., Gerotziafas, G., et al. Cardiovascular symposium on perspectives in long COVID. Clinical and Applied Thrombosis/Hemostasis, 31:10760296251319963, 2025.
9. Kempaiah, P., Libertin, C.R., Chitale, R.A., Naeyma, I., Pleqi, V., Sheele, J.M., et al. Decoding immuno-competence: a novel analysis of complete blood cell count data in COVID-19 outcomes. Biomedicines, 12(4):871, 2024.
10. Rajani, A.J., Raval, D.M., Chitale, R.A., Kempaiah, P., Elwasila, S.M., Durvasula, R., et al. Half a century in hiding: a unique case of tuberculoid leprosy with an unprecedented incubation period. The American Journal of Case Reports, 25:e942048-1, 2024.
11. Wilson, M.D., Kwofie, S.K., Asiedu, S.O., Kempaiah, P., Gupta, Y. and Durvasula, R.V. Use of mycolactone (MLN) and derivatives thereof for treatment of microbial infections. US Patent App. 18/345,605, 2024.
12. Cortés, P., Elsayed, A.A., Stancampiano, F.F., Barusco, F.M., Shapiro, B.P., Bi, Y., et al. Clinical and genetic predictors of cardiac dysfunction assessed by echocardiography in patients with hereditary hemochromatosis. The International Journal of Cardiovascular Imaging, 40(1):45-53, 2024.
13. Gupta, Y., Goicoechea, S., Vance, J., Trujillo, A.P., Alok, A., Kwofie, S.K., Rathi, B., et al. Target-based rational improvement strategies and pitfalls in Leishmania drug discovery. In: Natural Product Based Drug Discovery Against Human Parasites: Opportunities…, 2023.
14. Sakyi, P.O., Amewu, R.K., Devine, R.N.O.A., Kempaiah, P. and Kwofie, S.K. Versatile structurally diverse natural products and their semisynthetic analogs as potential antileishmanial drugs. In: Natural Product Based Drug Discovery Against Human Parasites: Opportunities…, 2023.
15. Rajani, A.J., Roach, D., Raval, D., Amin, J., Kempaiah, P., Chitale, R., et al. A systemic review of Mycobacterium nebraskense case reports up to October 2023, featuring our unique case study. The International Journal of Mycobacteriology, 12(4):443-447, 2023.
16. Cortes, P., Elsayed, A., Stancampiano, F., Barusco, F., Shapiro, B., Bi, Y., et al. Echocardiographic analysis of predictors of cardiac dysfunction in patients with hereditary hemochromatosis. Official Journal of the American College of Gastroenterology, 118(10S), 2023.
17. Gupta, Y., Savytskyi, O.V., Coban, M., Venugopal, A., Pleqi, V., Weber, C.A., et al. Protein structure-based in-silico approaches to drug discovery: guide to COVID-19 therapeutics. Molecular Aspects of Medicine, 91:101151, 2023.
18. Libertin, C.R., Kempaiah, P., Gupta, Y., Fair, J.M., van Regenmortel, M.H.V., et al. Data structuring may prevent ambiguity and improve personalized medical prognosis. Molecular Aspects of Medicine, 91:101142, 2023.
19. Asiedu, S.O., Gupta, Y., Nicolaescu, V., Gula, H., Caulfield, T.R., Durvasula, R., et al. Mycolactone: a broad spectrum multitarget antiviral active in the picomolar range for COVID-19 prevention and cure. International Journal of Molecular Sciences, 24(8):7151, 2023.
20. Flieger, S., Takagaki, M., Kondo, N., Lutz, M.R. Jr., Gupta, Y., Ueda, H., Sakurai, Y., et al. Carborane-containing hydroxamate MMP ligands for the treatment of tumors using boron neutron capture therapy (BNCT): efficacy without tumor cell entry. International Journal of Molecular Sciences, 24(8):6973, 2023.

Personal Details

https://scholar.google.com/citations?user=p1XZ9TcAAAAJ&hl=en

https://www.researchgate.net/profile/Prakasha-Kempaiah-3

https://orcid.org/0000-0002-2901-0339

WoS Researcher ID: ABC-6485-2020